La FDA met en garde contre une utilisation incorrecte du test COVID-19 à domicile nécessitant un prélèvement nasal, La FDA met en garde contre une utilisation incorrecte du test COVID-19 à domicile nécessitant un prélèvement nasal

A medical worker takes a écouvillon sample from a child for nucleic acid test at a testing site in Futian district of Shenzhen, South China’s Guangdong province, Jan 9, 2022. [Photo/Xinhua]

SHENZHEN — Government offices, enterprises, and businesses in the southern Chinese metropolis of Shenzhen to resume normal work and production from Monday as the latest COVID-19 resurgence subsides, les autorités locales ont déclaré dimanche.

The city also resume bus and subway services from Monday, according to a circular issued by the Shenzhen COVID-19 prevention and control headquarters.

Authorities are rolling out measures to ensure the safety and stability of industrial and supply chains, and orderly life and work for locals, the circular said.

After three citywide nucleic acid testings since March 14, the COVID-19 prevention and control situation in Shenzhen remains severe but is generally controllable, Ça disait.

The circular is effective from March 21 to March 27.